The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmid ongoing efforts to bolster London's status as a premier destination for international listings, Hong Kong-based AS Watson is reportedly considering a delay to its planned dual IPO in London this autumn. According to reports, the owner of health and beauty retailer Superdrug is re-evaluating the timing of the debut, which was initially targeted for the second half of the year. This potential postponement by parent company CK Hutchison Holdings Limited represents a cautious shift in strategy during a critical window for the UK capital markets.
The consideration of a delay arrives as the UK retail environment faces headwinds; recent BRC Retail Sales Monitor data showed a modest 1.7% year-on-year growth for July 2026, significantly missing the 2.9% forecast per market data. This cooling consumer sentiment mirrors challenges faced by peers like Walgreens-owned Boots, which has also navigated complex strategic reviews regarding its ownership structure. The retail sector remains sensitive to broader inflationary pressures that have impacted operational margins across European markets.
In the equity markets, shares of CK Hutchison (0001.HK) stood at 70.45 HKD at the close of July 16, 2026. Investors are now looking toward official corporate updates for clarity on the IPO roadmap. Future market sentiment will likely be shaped by upcoming consumer confidence indices and central bank commentary, which will dictate whether the macroeconomic environment becomes more favorable for large-scale retail listings later in the fiscal year.